Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343)
Access Status
Fulltext not available
Authors
Serra, V.
Eichhorn, Pieter
García-García, C.
Ibrahim, Y.
Prudkin, L.
Sánchez, G.
Rodríguez, O.
Antón, P.
Parra, J.
Marlow, S.
Scaltriti, M.
Pérez-Garcia, J.
Prat, A.
Arribas, J.
Hahn, W.
Kim, S.
Baselga, J.
Date
2014Type
Journal Article
Metadata
Show full item recordCitation
Serra, V. and Eichhorn, P. and García-García, C. and Ibrahim, Y. and Prudkin, L. and Sánchez, G. and Rodríguez, O. et al. 2014. Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343). Journal of Clinical Investigation. 124 (3).
Source Title
Journal of Clinical Investigation
DOI
ISSN
School
School of Pharmacy and Biomedical Sciences